Curium, HIG Said to Compete for $2 Billion Cardinal Health Unit

Curium Pharma, a French maker of medical imaging supplies, and buyout firm HIG Capital are among suitors shortlisted in the bidding for Cardinal Health Inc.’s nuclear medicine business, people familiar with the matter said.

Cardinal has invited the remaining bidders to submit final offers by mid-May, the people said, asking not to be identified as the matter is private. A deal could value the business at about $2 billion or more, according to the people.

Bloomberg News first reported in March that Cardinal was weighing a potential sale of the nuclear medicine business. Cardinal said in September it ...